Toronto Liver Centre

Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection

Jordan J. Feld, Ira M. Jacobson, Christophe Hézode et al. · New England Journal of Medicine · 2015 · 1.1K citations · Full text

Trends in the Prevalence of Metabolic Syndrome in the United States, 2011-2016

Grishma Hirode, Robert J. Wong · JAMA · 2020 · 900 citations · Full text

Obesity, Metabolic Syndrome, Nutrition +12

Treatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin

Jordan J. Feld, Kris V. Kowdley, Eoin Coakley et al. · New England Journal of Medicine · 2014 · 898 citations · Full text

Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial

Edward Gane, Wai Kay Seto, Henry Lik‐Yuen Chan et al. · ˜The œLancet. Gastroenterology & hepatology · 2016 · 535 citations

Hepatology, Viral Hepatitis, Hepatitis B +9

Feasibility and Diagnostic Performance of the Fibroscan XL Probe for Liver Stiffness Measurement in Overweight and Obese Patients

Robert P. Myers, Gilles Pomier–Layrargues, Richard Kirsch et al. · Hepatology · 2011 · 489 citations